Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
Status:
Recruiting
Trial end date:
2022-06-20
Target enrollment:
Participant gender:
Summary
This study will examine the efficacy and safety of tivanisiran sodium eye drops versus
vehicle after a 2-week run-in phase when dosed once daily for 3 months in subjects with signs
and symptoms of dry eye disease (DED) due to Sjögren's Syndrome.